Development of novel inhibitors against SARS-CoV-2 3CLpro
Xu, Y.C., Zang, Y., Zhou, Y.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
3C-like proteinase | 306 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  EC: 3.4.22.69 | ||
UniProt | |||||
Find proteins for P0DTD1 (Severe acute respiratory syndrome coronavirus 2) Explore P0DTD1  Go to UniProtKB:  P0DTD1 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P0DTD1 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
K9U (Subject of Investigation/LOI) Query on K9U | C [auth A], D [auth B] | (2S)-4-(3,4-dichlorophenyl)-1-[(2-oxidanylidene-1H-quinolin-4-yl)carbonyl]-N-[3,3,3-tris(fluoranyl)propyl]piperazine-2-carboxamide C24 H21 Cl2 F3 N4 O3 QFILEVBXLNLABP-FQEVSTJZSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 51.616 | α = 90 |
b = 81.708 | β = 97.19 |
c = 89.079 | γ = 90 |
Software Name | Purpose |
---|---|
HKL-2000 | data scaling |
PHASER | phasing |
PHENIX | refinement |
PDB_EXTRACT | data extraction |
HKL-2000 | data reduction |